Generic Fluticasone –Salmeterol Inhaler for COPD Matches Branded Product
(MedPage Today) -- A generic fluticasone-salmeterol (Wixela Inhub) maintenance inhaler was clinically equivalent to name-brand Advair Diskus for chronic obstructive pulmonary disease (COPD), a propensity score-matched cohort study found.
With... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - August 7, 2023 Category: Primary Care Source Type: news
Lannett Signs Agreement To Be Exclusive Distributor Of Generic Flovent(R) Diskus(R)
Company Extends Distribution Term for Generic ADVAIR DISKUS®
PHILADELPHIA, Aug. 17, 2020 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an exclusive U.S. distribution agreemen... Biopharmaceuticals, Generics, Distribution Lannett Company, Flovent, Diskus, Fluticasone Propionate Powder Inhaler (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 17, 2020 Category: Pharmaceuticals Source Type: news
Cipla submits application with USFDA for generic version of asthma drug
Drug major Cipla on Monday said it has submitted an application with the US health regulator for a generic version of GSK's Advair Diskus, which is used in the treatment of asthma and other respiratory disorders. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 17, 2020 Category: Pharmaceuticals Source Type: news
Pharmascience Inc. Launches pms-FLUTICASONE PROPIONATE/SALMETEROL DPI for the Maintenance Treatment of Asthma and COPD
MONTREAL, March 18, 2020 -- (Healthcare Sales & Marketing Network) - Pharmascience Inc. is proud to bring to market a new product for the maintenance treatment of asthma and COPD. pms-FLUTICASONE PROPIONATE/SALMETEROL DPI, a generic alternative to ADVAIR ... Biopharmaceuticals, Generics, Drug Delivery, Product Launch Pharmascience, FLUTICASONE, SALMETEROL, ADVAIR DISKUS, COPD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 18, 2020 Category: Pharmaceuticals Source Type: news
Airduo Digihaler (Fluticasone Propionate and Salmeterol Inhalation Powder) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 6, 2020 Category: Drugs & Pharmacology Source Type: news
Lannett Enters Into Distribution Agreement For Generic ADVAIR DISKUS(R)
PHILADELPHIA, Oct. 1, 2019 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an exclusive U.S. distribution agreement for the therapeutically equivalent generic of ADVAIR DISKUS® (F... Biopharmaceuticals, Generics, Distribution Lannett Company, ADVAIR DISKUS, Fluticasone Propionate (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 1, 2019 Category: Pharmaceuticals Source Type: news
FDA Approves AirDuo Digihaler (fluticasone propionate and salmeterol) Inhalation Powder for Asthma
JERUSALEM and PARSIPPANY, N.J., July 15, 2019– Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved AirDuo® Digihaler™ (fluticasone propionate 113... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 15, 2019 Category: Drugs & Pharmacology Source Type: news
10 New Drugs for Primary Care: Q1 2019
Highlights: The first liquid solution of colchicine for prophylaxis of gout, the first generic version of Advair Diskus,® and 8 more new and approved drugs. (Source: ConsultantLive)
Source: ConsultantLive - April 11, 2019 Category: Internal Medicine Authors: Sydney Jennings Tags: ADHD Asthma COPD Depression Gout Headache and Migraine HIV AIDS Source Type: news
Wixela Inhub (Fluticasone Propionate and Salmeterol Inhalation Powder) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 21, 2019 Category: Drugs & Pharmacology Source Type: news
Touting pricetag, Mylan launches Advair generic
Mylan (NSDQ:MYL) today announced the launch of its Wixela Inhub product, a generic for GlaxoSmithKline‘s (NYSE:GSK) Advair Diskus device, for people with asthma or chronic obstructive pulmonary disease.
The company touted that its device’s list price is 70% less than Advair Diskus and 67% less than GSK’s generic.
Get the full story at our sister site, Drug Delivery Business News.
The post Touting pricetag, Mylan launches Advair generic appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 12, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Drug-Device Combinations Featured Food & Drug Administration (FDA) Pharmaceuticals Wall Street Beat GlaxoSmithKline plc Mylan Source Type: news
First Generic Version of Advair Diskus Approved for Asthma, COPD
Title: First Generic Version of Advair Diskus Approved for Asthma, COPDCategory: Health NewsCreated: 1/31/2019 12:00:00 AMLast Editorial Review: 2/1/2019 12:00:00 AM (Source: MedicineNet Asthma General)
Source: MedicineNet Asthma General - February 1, 2019 Category: Respiratory Medicine Source Type: news
FDA approves generic version of Advair Diskus for asthma, COPD
The U.S. Food and Drug Administration today approved the first generic form of the popular asthma inhaler Advair Diskus, according to the agency. (Source: Health News - UPI.com)
Source: Health News - UPI.com - January 31, 2019 Category: Consumer Health News Source Type: news
FDA Approves Wixela Inhub (fluticasone propionate and salmeterol inhalation powder, USP), First Generic of Advair Diskus
HERTFORDSHIRE, England and PITTSBURGH, Jan. 31, 2019 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced the U.S. Food and Drug Administration (FDA) approval of Wixela Inhub (fluticasone propionate and salmeterol inhalation powder, USP), the... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - January 31, 2019 Category: Drugs & Pharmacology Source Type: news
FDA Approves First Generic Version of Advair for Asthma, COPD
THURSDAY, Jan. 31, 2019 -- The first generic form of the Advair Diskus (fluticasone propionate and salmeterol inhalation powder) inhaler has been approved by the U.S. Food and Drug Administration.
The medication can now be used to treat children... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 31, 2019 Category: Pharmaceuticals Source Type: news
First Generic Version of Advair Diskus Approved for Asthma, COPD
THURSDAY, Jan. 31, 2019 -- The first generic form of the Advair Diskus (fluticasone propionate and salmeterol inhalation powder) inhaler has been approved by the U.S. Food and Drug Administration.
It can now be used to treat children aged 4 or... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 31, 2019 Category: General Medicine Source Type: news
